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Exposure to chronic stress is frequently accompanied by cogni-
tive and affective disorders in association with neurostructural
adaptations. Chronic stress was previously shown to trigger
Alzheimer’s-like neuropathology, which is characterized by Tau hyper-
phosphorylation and missorting into dendritic spines followed by
memory deficits. Here, we demonstrate that stress-driven hippo-
campal deficits in wild-type mice are accompanied by synaptic mis-
sorting of Tau and enhanced Fyn/GluN2B-driven synaptic signaling.
In contrast, mice lacking Tau [Tau knockout (Tau-KO) mice] do not
exhibit stress-induced pathological behaviors and atrophy of hippo-
campal dendrites or deficits of hippocampal connectivity. These find-
ings implicate Tau as an essential mediator of the adverse effects
of stress on brain structure and function.
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The cytoskeletal protein Tau is implicated in the establishmentof Alzheimer’s disease (AD) (1) as well as excitotoxicity (1)
and, more recently, epilepsy (2, 3). Exposure to stressful condi-
tions induces depressive behavior and memory deficits in both
rodents and humans (4–8). Studies in rodents have shown that
chronic stress triggers Tau hyperphosphorylation, a key patho-
genic mechanism in AD, and results in cognitive and mood
deficits (9–13); however, those studies do not provide direct
evidence for a role of Tau in stress-evoked brain pathology.
Given that Tau plays an important role in regulating neuronal
architecture and function through its interaction with various
cellular targets (e.g., tubulin and Fyn) (14), we hypothesized that
Tau mediates the deleterious actions of stress on brain structure
and function.
To test the above hypothesis, we compared the impact of chronic
unpredictable stress (CUS) (11, 15) in mice carrying a null mutation
of the mapt gene [Tau knockout (Tau-KO) mice] (16) with their
wild-type (WT) littermates. Three well-characterized behavioral
endpoints (cognition, coping styles, and anxiety) that are disrupted
by CUS served as the primary assay endpoints; these were com-
plemented with measures of hippocampal structural and functional
integrity. The hippocampus is a central component of the neuro-
circuitries that control these behaviors and displays overt lesions in
both stress- and Tau-related pathologies; in the latter, the hippo-
campus is one of the earliest brain regions to show signs of neu-
rodegeneration (1, 4, 7, 10–13, 17).
Results
Deleterious Effects of Stress on Memory and Mood Are Abrogated in
the Absence of Tau Protein. Cognition, mood, and anxiety are in-
terdependent behavioral domains that exhibit complex inter-
actions (5). Different forms of memory were assessed after
exposure of WT and Tau-KO mice to the CUS paradigm; the test
battery included the Y-maze, Morris water maze (MWM), and the
novel object recognition test (NOR). Anxiety was evaluated using
the elevated plus maze (EPM), and coping styles and anhedonia
were assessed using the forced swim test (FST) and the sucrose
consumption test (SCT).
Two-way ANOVA analysis of the Y-maze data revealed CUS ×
Genotype interactions for both, distance traveled [F(1, 65) = 4.024,
P = 0.04], and time spent [F(1, 65) = 4.614, P = 0.03] in the novel
arm of the apparatus. Exposure to CUS resulted in deficits in
spatial memory in WT (pdist = 0.02; ptime = 0.02), but not Tau-KO
(pdist = 0.98; ptime = 0.95), mice; no differences were found be-
tween WT and Tau-KO control (nonstressed) animals (pdist =
0.84; ptime = 0.77) (Fig. 1A and SI Appendix, Fig. S1). Total dis-
tance traveled in the three arms of the maze did not differ be-
tween any of the groups (Fig. 1B). Results from the MWM test
confirmed that CUS induces impairments in spatial learning/
memory in WT, but not Tau-KO, mice [significant CUS × Ge-
notype interaction in distance swum to reach the escape platform
[F(1, 35) = 7.467, P = 0.01]; CUS increased the distance swum in
WT mice only (P ≤ 0.05) (Fig. 1C). The NOR test showed that
recognition memory was also disrupted by CUS in WT, but not
Tau-KO, mice. Specifically, we found a CUS × Genotype in-
teraction [F(1, 37) = 4.387, P = 0.04] on the discrimination index.
Importantly, this index was reduced by CUS in WT (pWT = 0.01),
but not Tau-KO (pKO = 0.83), mice; control WT and Tau-KO
mice did not differ on this parameter (P = 0.60) (Fig. 1D).
Testing in the EPM (Fig. 1E) showed that CUS elicits an
anxiogenic phenotype in WT, but not Tau-KO, animals [two-way
ANOVA, CUS ×Genotype interaction: F(1, 84) = 4.004, P = 0.04;
overall effect of CUS (F(1, 84) = 6.296, P = 0.01)] with WT ani-
mals spending significantly less time in the open arms of the
maze (pWT = 0.01 vs. pKO = 0.98). Furthermore, we used two
different tests to monitor active or passive coping styles (18) and
anhedonic behavior. FST revealed a CUS × Genotype in-
teraction [F(1, 73) = 4.071, P = 0.04] and an overall effect of CUS
[F(1, 73) = 6.229, P = 0.01] on time of immobility (passive
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behavior). Furthermore, CUS-treated WT mice displayed longer
periods of immobility (P = 0.01) than Tau-KO (P = 0.98) mice,
compared with their respective non-CUS-treated (control)
counterparts (Fig. 1F); these findings were confirmed by mea-
suring latency to immobility (SI Appendix, Fig. S2). Results
from the SCT, which provides an index of anhedonia or appetite
(a cardinal symptom of depression in humans), showed a sig-
nificant CUS × Genotype interaction [F(1, 30) = 5.906, P = 0.02],
with post hoc analysis revealing reduced sucrose consumption in
WT (P = 0.03), but not Tau-KO (P = 0.94), mice (Fig. 1G,
Right). The above sets of data demonstrate that Tau-KO mice are
resistant to the behavioral effects of stress on memory, coping
styles, and anxiety.
Tau Deletion Does Not Interfere with the Endocrine Response to Stress.
The ability of chronic stress to interfere with cognitive and affective
functions is largely attributable to the actions of glucocorticoids
[e.g., corticosterone (CORT) in rodents], which are released in
response to stress (6). In contrast to the genotype-specific behav-
ioral responses to CUS, both WT and Tau-KO mice displayed
similar elevations in blood CORT and body mass loss following the
CUS paradigm (SI Appendix, Table S1) and responded to an acute
stressor (4-min restraint) with similar increases in CORT secretion
(SI Appendix, Table S2). These observations suggest that the above
Tau-dependent detrimental effects of stress on behavior are not due
to differential regulation of the endocrine response to stress in WT
and Tau-KO animals.
Tau Ablation Attenuates Stress-Induced Disruption of Neuronal
Connectivity. Reductions in monoaminergic tone, specifically
of noradrenaline (NA) and serotonin (5-HT), play a central role
in mediating the detrimental effects of stress on cognition and
mood (19). Consistent with the failure of CUS to cause behavioral
changes in Tau-KOmice, NA and 5-HT levels in the hippocampus
were found to be altered in WT, but not in Tau-KO, mice (Fig. 2).
Specifically, we detected significant Genotype × CUS interactions
[F(1, 16) NA = 7.639, P = 0.01; F(1, 16) 5-HT = 6.954, P = 0.02], and
post hoc analysis revealed significant CUS-induced reductions in
hippocampal monoamine levels in WT (NA: P = 0.02; 5-HT: P =
0.04) vs. no changes in Tau-KO (NA: P = 0.96; 5-HT: P = 0.97)
animals (Fig. 2 A and B). Genotype did not influence the effect of
CUS on NA and 5-HT levels (NA: P = 0.95; 5-HT: P = 0.97).
Calculations of 5-HT turnover ratio from parallel measurement
of the 5-HT metabolite, 5-hydroxyindole acetic acid (5-HIAA),
confirmed that CUS altered 5-HT turnover in WT (P = 0.04), but
not Tau-KO (P = 0.99), animals, indicated by an interaction effect
between CUS and Genotype [F(1, 16) = 4.628, P = 0.04] (SI Ap-
pendix, Fig. S3). Examining hippocampal levels and turnover of
dopamine (DA) did not reveal any significant effect of CUS in
either WT or Tau-KO mice (Fig. 2A and SI Appendix, Fig. S3).
We next monitored the impact of stress on hippocampal syn-
aptic plasticity by measuring the inducibility of long-term po-
tentiation (LTP) in slice preparations (Fig. 2 C and D) (20).
Analysis of the LTP data revealed a significant CUS × Genotype
interaction [F(1, 27) = 6.283, P = 0.018] and overall effects of CUS
[F(1, 27) = 11.24, P = 0.002] and Genotype [F(1, 27) = 41.35, P <
0.0001]. In addition, post hoc analysis revealed that LTP was
reduced in slices from CUS-treated WT (P = 0.002), but not
CUS-treated Tau-KO (P = 0.92), mice compared with their
controls. Interestingly, LTP levels differed between WT and
Tau-KO animals (P < 0.0001). These changes were accompanied
by altered synaptic release probability, as assessed by monitoring
paired-pulse (PP) facilitation at different interstimulus intervals
(Fig. 2 E and F) (17): PP ratios (25 and 50 ms interpulse intervals)
Fig. 1. Tau ablation blocks stress-driven anxious, anhedonic, and passive coping behaviors as well as cognitive impairments. (A and B) Chronic unpredictable
stress (CUS) decreased the distance traveled by WT animals traveled in the novel arm of the Y-maze apparatus, indicating a deficit in spatial memory
(SI Appendix, Fig. S1); this deficit was not displayed by CUS-exposed Tau-KO animals. Note that both WT and Tau-KO covered similar distances in the maze.
(C) The Morris water maze (MWM) test revealed impairments of spatial learning/memory in WT, but not Tau-KO, animals that had been exposed to CUS as
CUS-WT animals traveled greater distances to reach the escape platform vs. control WT mice. (D) In contrast to Tau-KOs, WT animals displayed decreased
discrimination index after CUS exposure when tested in the novel object recognition (NOR) test; this suggests CUS-evoked impaired recognition memory in
WT animals. (E) Exposure to CUS produced higher levels of anxiety in WT, but not Tau-KO, mice, as seen by the reduced time spent in the open arms of the elevated
plus maze (EPM) in WT animals. (F) WT animals exposed to CUS exhibited increased immobility time in the forced swim test (FST), reflecting passive coping behavior
compared with WT controls (CON); no difference between CUS and CON Tau-KOs was found. (G) Reduced preference for the sucrose solution (which reflects
anhedonic behavior) was observed in CUS-exposed WT, but not Tau-KO, mice in the sucrose preference test (SPT), indicating their sensitivity to the effects of CUS.
Note that all treatment groups showed a similar preference for sucrose before the CUS paradigm. All data shown represent mean ± SEM (*P < 0.05).
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were subject to CUS × Genotype interactions [F(1, 27) 25 ms =
7.100, P = 0.012; F(1, 27) 50 ms = 9.148, P = 0.005], and Genotype
had an overall effect on this parameter [F(1, 27) 25 ms = 4.777, P =
0.037; F(1, 27) 50 ms = 5.034, P = 0.033]. Post hoc analysis revealed
that CUS decreases the probability of synaptic release in slices
of WT (p50ms = 0.02), but not Tau-KO (p50ms = 0.66), mice (Fig.
2 E and F). Interestingly, basal synaptic transmission, assessed
using input–output curves, did not differ between any of the groups
tested (SI Appendix, Fig. S4).
Next, we compared the effects of CUS on hippocampal neuro-
nal activity using manganese (Mn)-enhanced magnetic resonance
imaging (MEMRI) (21) to detect hippocampal neuronal activity;
Fig. 2. Hippocampal function and activity is differentially affected by stress in WT and Tau-KO animals. (A and B) Monoamine [dopamine (DA), nor-
adrenaline (NA), and serotonin (5HT)] levels in the hippocampi of control and CUS-treated WT (A) and Tau-KO (B) mice are shown. CUS decreased NA and 5HT
levels in WT, but not Tau-KO, animals. Metabolites and turnover rates of these monoamines in the various treatment groups are depicted in SI Appendix, Fig.
S3. (C and D) LTP, induced by 100 Hz stimulation, was significantly diminished in WT-CUS animals compared with WT CON. LTP was not altered by CUS
exposure in Tau-KO animals. (E and F) Paired-pulse facilitation was increased by CUS in WT, but not Tau-KO, animals, indicating reduced release probability in
the former group. (G) MEMRI coronal images show strong contrast enhancement in the hippocampus reflecting activity-dependent Manganese accumulation.
(H) MEMRI analysis revealed that CUS reduces hippocampal neuronal activity in both WT and Tau-KO mice, but to a significantly greater extent in WT-CUS
animals. All data shown represent mean ± SEM (*P < 0.05; ****P < 0.0001).
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the method allows evaluation of local neural activity because Mn
enters into neurons through calcium channels (21). Hippocampal
MEMRI intensity was normalized to a nonbrain region (masseter
muscle) (22). Data analysis showed a significant CUS × Geno-
type interaction [two-way ANOVA F(1, 44) = 10.64, P = 0.0021],
an overall CUS [F(1, 44) = 25.00, P < 0.0001], and a Genotype
effect [F(1, 44) = 56.63, P < 0.0001] (Fig. 2 G and H); it should be
noted that the CUS × Genotype interaction resulted from the
stronger CUS-induced reduction in neuronal activity in WT (P <
0.001) vs. Tau-KO (P = 0.02) mice. Finally, a significant differ-
ence of hippocampal neuronal activity was found between non-
stressed WT and Tau-KO mice (P < 0.001).
Neuronal Atrophy in Stressed Hippocampus Is Tau-Dependent. Chronic
stress exerts profound effects on neuronal architecture in the
hippocampal formation, in particular on dendritic arborization in
the dentate gyrus, CA1 and CA3 neurons (4, 6–8); these structural
changes correlate with CUS-induced emotional and cognitive im-
pairments (4, 7, 23). Examination of dendritic lengths in the various
subfields of the rostral hippocampus by 3D reconstruction analysis
of Golgi-stained tissues showed significant CUS ×Genotype effects
on the dendritic lengths of dentate granule [F(1, 117) = 3.944, P =
0.04], CA1 (specifically, apical dendrites) [F(1, 94) = 4.440, P = 0.03],
and CA3 pyramidal [F(1, 75) = 8.481, P = 0.004] neurons. Overall
effects of CUS were found on dendritic lengths in the dentate
[F(1, 117) = 11.310, P = 0.001] and CA1 [F(1, 94) = 7.704, P = 0.006]
subfields, and Genotype influenced dentate [F(1, 117 = 7.109, P =
0.008] and CA3 [F(1, 75) = 6.641, P = 0.01] neuron dendritic
lengths. Post hoc analysis revealed that CUS significantly reduced
dendritic lengths of hippocampal neurons in WT (pDG = 0.001;
Fig. 3. Stress-driven structural remodeling of hippocampal neurons depends on Tau protein. (A–F) Golgi-impregnated hippocampal sections were used to
examine the effects of CUS on neuronal atrophy and dendritic lengths. Exposure to chronic stress (CUS) resulted in neuronal atrophy in the dentate gyrus, CA3
and CA1 subfields of WT animals, as shown by 3D neuronal reconstruction (A, C, and E) and morphometry (B, D, and F). In contrast, Tau-KO mice did not show
any atrophy after exposure to CUS. (G) CUS was found to lead to a reduction in dendritic arborization of DG neurons in WT-CUS vs. CON-WT mice, whereas
this parameter was not altered in CUS-treated Tau-KO mice (SI Appendix, Fig. S5). All numeric data represent mean ± SEM (*P < 0.05; **P < 0.01).
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pCA3 = 0.02; pCA1 = 0.005), but not Tau-KO (pDG = 0.75; pCA3 =
0.62; pCA1 = 0.96), mice (Fig. 3 A–F). No differences in apical
dendritic length were found between control WT and Tau-KO an-
imals (pDG = 0.96, pCA3 = 0.99, pCA1 = 0.27). Consistent with pre-
vious findings, CUS did not influence the structure of the basal
dendrites of CA1 and CA3 pyramidal cells (23). These alterations in
dendritic atrophy were complemented by the results of Scholl
analyses that showed that CUS reduces dendritic arborization in the
hippocampus of WT, but not of Tau-KO, animals (Fig. 3G and SI
Appendix, Fig. S5).
Chronic Stress Evokes Tau Hyperphosphorylation and Missorting in
Synapses. Tau hyperphosphorylation and missorting in dendrites
and synapses are considered key mechanisms in the neuronal
damage and atrophy that characterize AD (24–27). In light of the
above evidence that Tau is required for the manifestation of
CUS-induced neuronal atrophy and dysfunction (Figs. 2 and 3),
we next monitored the impact of CUS on Tau and its phosphory-
lation status in cytosolic and synaptosomal fractions from the hip-
pocampi of WT mice (Fig. 4 A–C). CUS induced a significant
increase in cytosolic levels of total Tau (t test, P = 0.03), ac-
companied by increased levels of Thr231-, Ser262-, and Ser396/
404-Tau phospho-epitopes (p231 = 0.03; p262 = 0.0001; p396/404 =
0.018, respectively; Fig. 4 D and E); these findings indicate cy-
toplasmic accumulation of Tau. Although Tau is found mainly in
the neuronal axon and soma, previous work suggests that Tau is
missorted and accumulated at synapses under pathological con-
ditions (24, 28). We show here that CUS elevates total Tau levels
(P = 0.02) as well the levels of pSer262-Tau and pSer396/404-Tau
isoforms (P = 0.04, P = 0.03, respectively) in synaptosomal fractions
from WT hippocampi, indicating synaptic accumulation of these
phospho-Tau forms (Fig. 4 D and E). Because the effects of chronic
stress on neuronal structure and function are largely attributed to
glucocorticoids (GC) (6, 7) and previous work from our team and
others points toward the role of the glucocorticoid receptor (GR) in
Tau hyperphosphorylation (10, 11), we next examined whether the
actions of CUS could be reproduced by chronic administration
of a potent synthetic GR agonist (dexamethasone). Immuno-
blotting analysis of fractionated hippocampal tissue (Fig. 4A)
showed that GC treatment increases both cytosolic and syn-
aptosomal levels of total Tau, as well as of phosphorylated Tau
(SI Appendix, Fig. S6). These findings were substantiated by
transmission electron microscopy (TEM) analysis of immuno-
gold Tau-stained hippocampal sections (Fig. 4 G and H and SI
Appendix, Fig. S7). This analysis demonstrated that GC exposure
elevates the density of total Tau staining in dendrites and syn-
apses (P = 0.0002 and P = 0.0001, respectively). Together, the
above biochemical and TEM results suggest that CUS and GC
lead to cytoplasmic accumulation of Tau as well as its missorting
to hippocampal synapses, possibly leading to disturbed synaptic
function, as recently suggested (24, 28).
Tau was recently found to participate in synaptic signaling by
interacting with Fyn (29), a Src family kinase, that selectively
modulates the function of the GluN2B-containing NMDA re-
ceptors (NMDARs) by phosphorylating the Y1472 residue of the
GluN2B subunit (30). Synaptic missorting of Tau has been sug-
gested to underpin synaptic toxicity by enhancing the post-
synaptic targeting of Fyn (24), subsequently linking NMDARs
to downstream synaptic excitotoxic signaling (24, 30). We show
here that exposure to CUS increases levels of Fyn in postsynaptic
density (PSD) fractions obtained from the hippocampi of WT (P =
0.02), but not Tau-KO (P = 0.95), mice [F(1, 51) = 5.94, P = 0.01;
Fig. 4 I–K]. Moreover, in line with previous reports (24), we found
that Tau-KO animals express lower levels of PSD-associated
Fyn [F(1, 51) = 17.2, P = 0.0001]. Furthermore, we show that only
WT mice respond to CUS with higher PSD levels of Y1472-
phosphorylated GluN2B [P = 0.01; F(1, 50) = 4.10, P = 0.04] and
elevated levels of total GluN2B receptors in the PSD (P = 0.03;
Fig. 4 J and K). Briefly, these observations are consistent with
the view that Tau plays an essential mediatory role in Y1472
phosphorylation of GluN2B, an event that helps stabilize GluN2B
receptors within the PSD enhancing its synaptic localization (24),
whereas the absence of Tau attenuates the above stress-driven
signaling.
In summary, the neurochemical, electrophysiological, molecu-
lar, and neuroanatomical evidence reported in this section dem-
onstrates that CUS differentially influences the structural and
functional integrity of the hippocampus in WT and Tau-KO
mice; the latter “escape” stress-induced disruption of the hip-
pocampal circuitry (cf. 7).
Discussion
The experiments reported here demonstrate that Tau protein is
a critical mediator of the neuronal dysfunction and associated
cognitive and affective impairments seen after the experience of
chronic stress; they introduce a Tau-dependent cellular mecha-
nism to explain the well-known causal relationship between
stress and hippocampal malfunction (4, 6).
Clinical and preclinical studies have shown that prolonged
exposure to stressful conditions impairs structural and functional
plasticity of the hippocampal formation related to stress-driven
cognitive and mood deficits (7, 8, 23). A key finding of this an-
imal study is that Tau is essential for chronic stress to induce
dendritic atrophy and interrupt neuronal connectivity in the
hippocampus. Consistent with these structural and functional
observations, animals lacking Tau were spared from the delete-
rious behavioral effects of chronic stress. Although our knowl-
edge about the cellular mechanisms through which stress induces
structural and functional remodeling of the hippocampus is
limited, we previously showed that chronic stress increases the
levels of two kinases (GSK3β and cdk5) that play a key role in the
generation of aberrantly hyperphosphorylated Tau (11, 31). We
now show that chronic stress leads to an accumulation of Tau and
different isoforms of hyperphosphorylated Tau in the cytosolic and
synaptic compartments of hippocampal neurons. Notably, phos-
phorylation in two epitopes of Tau, Thr231 and Ser262, is known to
reduce the microtubule-binding capacity of Tau, which subsequently
results in destabilization of the neuronal cytoskeleton, disrupted
intracellular trafficking, and hippocampal atrophy in AD (26, 32–
35). Recent evidence demonstrated that the intracellular distribu-
tion of Tau depends critically on the phosphorylation status of the
protein (36). Accordingly, hyperphosphorylation of Tau seems to be
necessary for missorting of Tau at synapses as only pseudophos-
phorylated Tau (which mimics hyperphosphorylated Tau), but not
phosphorylation-deficient Tau, is mislocalized and accumulated in
dendritic spines (25). Importantly, while amyloid β is a well-known
trigger of Tau missorting and dendritic collapse (28, 37), our current
findings represent the first demonstration, to our knowledge, that
an exogenous stimulus—chronic stress—can also induce Tau mis-
sorting; they add to our mechanistic understanding of the impact of
stressful conditions on the development of nonfamilial forms of
AD, as previously suggested (38).
Tau missorting at dendritic spines is suggested to represent
an early event in AD, preceding the manifestation of detect-
able neurodegenerative processes (25, 26). Although the precise
mechanisms through which endogenous Tau facilitates neuronal
deficits are still under investigation, a recently suggested pathway
involves enhanced Tau-mediated postsynaptic targeting of Fyn
(24); the latter is known to selectively modulate the function
of GluN2B-containing NMDARs by phosphorylation of the
GluN2B at its Y1472 epitope, an event that stabilizes GluN2B at
the postsynaptic density, thus linking NMDARs to downstream
excitotoxic cascades (24, 30). In addition to adding support for
the view that stress and AD share common neurobiological
substrates (31), the results presented here suggest a plausible
Tau-dependent mechanism (Fig. 5) through which chronic stress
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Fig. 4. Tau accumulation and missorting in the synaptic compartment of mice exposed to chronic stress. (A) Schematic showing the subcellular frac-
tionation protocol used to prepare synaptosomal (LP1) and cytosolic (S3) fractions (SI Appendix) and (B) the different Tau phospho-epitopes monitored
in this study. (C ) Immunoblots showing synaptic proteins (e.g., PSD-95) and receptor (e.g., GluN2B) detected in synaptosomal, but not in cytosolic,
preparations. (D–F ) Exposure to CUS increased the cytosolic levels of total Tau and pThr231-, pSer262-, and pSer396/404-Tau isoforms in the hippocampi
of WT mice. In addition, CUS boosted the overall levels of Tau, as well as pSer262 and pSer396/404-Tau in the synaptosomal fractions. (G and H)
Transmission electron micrographs of immunogold-stained Tau in the hippocampus, showing that glucocorticoid (GC) treatment increases the amount
of Tau in both dendritic and synaptic compartments. (I) Schematic of method used to isolate postsynaptic density (PSD) and extrasynaptic (Extra)
fractions from hippocampal tissue and immunodetection of PSD95 and synaptophysin in the PSD and extrasynaptic fractions, respectively. (J and K ) CUS
increases Fyn protein levels in the PSD, as well as levels of total and pY1472-GluN2B in the PSD of WT, but not Tau-KO, animals. All numeric data
represent mean ± SEM (*P < 0.05; ***P < 0.001).
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initiates a signaling cascade that culminates in neuronal damage.
Interestingly, the same mechanism was previously proposed to
operate in other neuropathological conditions such as stroke and
AD (24, 39). Note that NMDARs are also shown to be involved in
stress-driven neurotoxicity (40) as blockade of NMDARs, but not
AMPA receptors (AMPARs), attenuates the neuroremodeling ac-
tions of stress (41, 42).
The current study reveals the neuroprotective role of Tau re-
duction against the establishment of stress-driven hippocampal
pathology. This observation is in line with other approaches using
Tau-lowering strategies to tackle neuropathologies with diverse
etiology (1, 3, 24). Interestingly, in line with previous reports (14,
16, 43 but also see ref. 44), the absence of Tau does not impact on
the behavioral, neurostructural, or endocrine profile of adult ani-
mals under normal conditions, does not interfere with the endo-
crine response to stress, and thus does not pose a threat to the
organism’s survival. Our findings highlight Tau protein and its
synaptic missorting as an essential mediator of the deleterious ef-
fects of stress on hippocampal structure and function, suggesting
Tau as a key regulator of neuronal plasticity. Indeed, previous
studies have shown that Tau hyperphosphorylation and neuronal/
synaptic atrophy is also triggered by different intrinsic and extrinsic
conditions such as acute stress (45), hypothermia (46), hypo-
metabolism (47), and hibernation (48) in a reversible way. How-
ever, repeated/prolonged exposure to stress is known to result in
sustained Tau hyperphosphorylation as well as insoluble neuro-
damaging Tau aggregates (11, 49, 50); additionally, reversibility of
stress-induced neuronal atrophy is lost in the aged brain (51). Thus,
future studies are necessary to clarify the mechanistic role of Tau in
the stress-recovery process as well as to identify the potential
threshold/“point of no return” between Tau-related neuroplasticity
and neuropathology under stressful conditions. Based on the Tau
involvement in different and interconnected behavioral domains
affected by stress, and the emerging view that chronic stress shifts
the overall brain connectome involving both hippocampal and
frontostriatal “disconnection and reconnection” (7, 52), future
work should further examine the impact of Tau on the overall
stressed brain neuromatrix, monitoring the suggested switch
between circuitries along the transition from acute stress con-
dition to chronic stress brain construct (53).
Materials and Methods
Animals and Treatments. WT and Tau-KO male mice (C57BL/6J background),
aged 4–6 mo, were used in this study (16); mice were group-housed (five
animals per cage) with ad libitum access to food and water under standard
environmental conditions (8:00 AM–8 PM light cycle; 22 °C; 55% humidity).
All experiments were conducted in accordance with the Portuguese national
authority for animal experimentation, Direcção Geral de Veterinária (ID:
DGV9457), and Directive 2010/63/EU of the European Parliament and
Council. Animals from each genotype were either (i) exposed to a CUS
paradigm during the daily period of light or (ii) left undisturbed in their
home cages (control, or CON). The CUS paradigm consisted of exposure to
either restraint, vibrating platform, overcrowding, or a hot air stream on
consecutive days, for 6 wk (11, 15). To monitor the efficacy of CUS, body
weights were measured weekly, and blood serum was collected at the end
of the stress period and assayed for corticosterone levels (ICN Biomedical).
Experiments in mice were replicated four times (10–12 mice per group for
each experimental replicate). Furthermore, in another experiment, male
Wister rats, aged 4–5 mo, were treated with the synthetic glucocorticoid
dexamethasone (DEX) for 15 d (daily s.c. injections of 300 μg/kg dissolved in
sesame oil containing 0.01% ethanol); control animals received sesame oil (five
animals per group). This dose of DEX was used because DEX is hampered in
brain penetration as it is a substrate of the multidrug-resistant P-glycopro-
tein (54, 55).
Behavioral Analysis.
Y-maze.All animals were subjected to a two-trial test to assess spatial memory
using a Y-maze (33 cm × 7 cm × 15 cm). The three arms were randomly
designated as start, novel, and old arm; visual cues were placed on the edges
of each arm. In the first trial (10 min), animals were allowed to explore only
two arms. For the second trial (5 min), mice were placed back in the start arm
but had free access to all arms of the maze. Trials were captured using a
video-tracking system (Viewpoint); data are expressed as percentage of
distance traveled and time spent in the novel arm.
Morris water maze. The maze consisted of a white circular pool (diameter:
170 cm; depth: 50 cm), filled with tap water (23 ± 1 °C; 25 cm of depth) and
was divided into quadrants by imaginary lines; the maze was placed in a
dimly lit roomwith extrinsic clues. During testing, a transparent escape platform
(14 cm in diameter; 30 cm high), invisible to the animals, was placed in the same
quadrant during five consecutive days. Each test session consisted of four trials
Fig. 5. Working model of how Tau plays a central role in the cellular processes underpinning the adverse effects of stress on hippocampal function. The
model proposes that chronic stress leads to the hyperphosphorylation of specific phospho-Tau isotopes, which results in (i) dissociation of Tau from micro-
tubules (MT), (ii) cytoplasmic accumulation of Tau, and (iii) missorting of Tau in dendritic spines. The latter targets the Src kinase Fyn to the postsynaptic
density (PSD; gray box) where it phosphorylates the Y1472 epitope of the NMDA receptor subunit GluN2B, thereby increasing the stability of NMDA receptors
within the PSD and coupling them to downstream excitotoxic cascades (24). These synaptic effects of stress depend critically on mediation by Tau, and the
absence of Tau protects against stress-induced brain pathology.
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(maximum 120 s). Trials were captured on a video-tracking system (Viewpoint).
The distance that animals swam to reach the hidden platform was recorded and
used to evaluate learning and memory performances (11, 56).
NOR. NOR was tested using an open arena (33 cm × 33 cm × 33 cm). After a
habituation period (3 sequential days), animals were allowed to explore two
identical (familiar) objects for 10 min. After 24 h, mice were returned to the
arena, where one of the familiar objects was replaced with a novel one
(different shape, color, and texture). All sessions were videotaped and
scored manually using Kinoscope software https://sourceforge.net/projects/
kinoscope/). A discrimination index was calculated using the following for-
mula: [(Novel Object/Novel Object + Familiar Object) − Familiar Object
(Novel Object + Familiar Object)] × 100.
Elevated plus maze.Animals were placed in an EPMapparatus consisting of two
open arms (50.8 cm × 10.2 cm) and two closed arms (50.8 cm × 10.2 cm ×
40.6 cm), elevated 72.4 cm above the floor in a dimly illuminated room.
The time spent in the open arms was monitored with an infrared camera
(MedPCIV, Med Associates Inc.) over a total of 5 min (56).
Forced swim test. Active and passive coping behavior was assessed using
the FST (18, 25). Briefly, mice were individually placed into transparent cyl-
inders filled with water (24 °C; depth 30 cm). A 5-min test session for each
mouse was recorded and trials were manually scored using Kinoscope soft-
ware (https://sourceforge.net/projects/kinoscope/). Passive coping behavior
was evaluated by immobility time and latency to immobility (18).
Sucrose preference test. Sucrose preference was tested in all animals (in-
dividually housed for 48 h) before the CUS paradigm was started. They re-
ceived two drinking bottles, one containing water, the other 2% (wt/vol)
sucrose. At the end of the CUS paradigm, animals were again monitored for
sucrose preference. Anhedonia (reduction in sucrose preference) was cal-
culated according to the following formula: sucrose preference = sucrose
intake/total intake] × 100.
Neurostructural Analysis. For 3D morphological analysis, animals (n = 5 per
group) were transcardially perfused with 0.9% saline. Brains were immersed
in a Golgi-Cox solution for 14 d and transferred to 30% sucrose before being
cut on a vibratome (coronal sections) and further processed as previously
described (15, 23). Dendritic arborization was analyzed in the dentate
gyrus, CA1, and CA3 of the dorsal hippocampus. Dendritic trees of indi-
vidual neurons (25–30 neurons/area/experimental group) were recon-
structed at 600× (oil) magnification using a motorized microscope (BX51,
Olympus). A 3D analysis of the reconstructed neurons was performed us-
ing NeuroExplorer software (Microbrightfield), which also provided den-
dritic lengths. 3D Sholl analysis was used to evaluate the arrangement of
the dendritic tree. For that purpose, the number of dendritic intersections
with concentric spheres positioned at radial intervals of 20 mm was de-
termined using NeuroExplorer software (MBF Bioscience) as previously
described (15, 23).
HPLC Analysis. Levels of monoamines (NA, DA, and 5-HT) and their metab-
olites [HVA (homovanillic acid), DOPAC (3,4-dihydroxyphenylacetic acid),
5-HIAA (5-hydroxyindoleacetic acid)] weremeasured using high-performance
liquid chromatography with electrochemical detection. Dorsal hippocampi
were homogenized and deproteinized (0.1 N perchloric acid solution, 7.9 mM
Na2S2O5, 1.3 mM Na2EDTA). After centrifugation (20,000 × g, 45 min), su-
pernatant was analyzed using a GBC LC 1150 HPLC pump (GBC Scientific
Equipment) coupled with a BAS-LC4C (Bioanalytical Systems Inc.) electro-
chemical detector (+800 mV), as previously described (56). Reverse-phase ion
pairing chromatography was used to assay monoamines and their metabo-
lites using an Aquasil C18HPLC column (250 × 4.6 mm, 5 μm; Thermo-
Electron). Samples were quantified by comparison of the area under the
curve against known external reference standards using a PC-compatible
HPLC software package (Chromatography Station) as previously described
(56). The limit of detection was 1 pg/20 μL (injection volume). Turnover rates
of 5-HT and DA (5-HIAA/5-HT as well as HVA/DA and DOPAC/DA, re-
spectively) were calculated as indices of serotonergic and dopaminergic ac-
tivity, respectively. Monoamine turnover rates are more reliable indices of
neurotransmission activity than absolute levels of monoamine, as they in-
tegrate synthesis, release, reuptake, and metabolism of neurotransmitters in
the synapse (56).
Electrophysiological Recordings. After brain removal in ice-cold sucrose-based
artificial cerebrospinal fluid solution [in mM: 2.5 KCl, 7 MgCl2, 1.25 NaH2PO4,
110 sucrose, 26 NaHCO3, 10 glucose, bubbled with carbogen gas (95% O2,
5% CO2)], 300-μm axial slices of dorsal hippocampus were prepared and
recorded (31 °C) in standard artificial cerebrospinal fluid [in mM: 124 NaCl,
2.5 KCl, 1 MgSO4, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10 glucose, bubbled
with carbogen gas (95% O2, 5% CO2)]. Both extracellular recordings [Mul-
ticlamp 700B amplifier (Axon Instruments) and borosilicate glass pipettes
with saline (3–5 MΩ)] and stimulation (bipolar tungsten electrode) were
performed in the middle of the stratum radiatum of CA1. Signals were low-
pass-filtered at 3 KHz and sampled at 10 KHz. The input–output relation was
monitored using a STG4002 stimulus isolating unit for Shaffer collaterals
stimulation [0.03 Hz (2–8 V); stimulus strength at 30–50% of the maximum
slope of the field excitatory postsynaptic potential (fEPSP)]. The paired pulse
ratio was assessed before LTP induction by giving two close stimuli of
varying interpulse interval (25, 50, 100, and 300 ms); ratio was calculated by
dividing the slope of fEPSP 2 by fEPSP 1 (baseline 0.03 Hz). LTP was elicited
by delivering three 1-s-long 100-Hz burst stimuli intervaled by 15 s. Final
slopes were calculated offline using the LTP software (20). All points of each
individual curve were normalized to the average value of the last 10-min
baseline. Averages of the slopes of the last 6-min recordings were used for
comparison of the LTP curves.
Manganese Enhanced MRI Scanning. MEMRI scans were acquired on a 7 T
Avance Biospec 70/30 scanner (Bruker BioSpin). For T1 contrast, enhancement
animals were injected i.p. with manganese chloride [50 mM MnCl2 × 4H2O
(Sigma) solution in 0.9% NaCl, adjusted to pH 7.0] using a fractionated in-
jection protocol to minimize toxic side effects (22). Eight doses of 20 mg/kg
MnCl2 were injected. Animals were positioned on a saddle-shaped, receive-
only coil in a prone position with stereotaxtical fixation. Body temperature
was controlled by a rectal thermometer (Thermalert TH-5, Physitemp In-
struments) and kept at 37 °C. Additionally, the pulse was monitored with a
plethysmographic pulse oxymeter (Nonin 8600V, Nonin Medical Inc.). T1w
images were acquired using a 3D gradient echo pulse sequence [echo time
(TE) = 3.2 ms, repetition time (TR) = 50 ms, matrix size = 128 × 106 × 106,
zero filled to 128 × 128 × 128, number of averages = 10, field of view = 16 ×
16 × 18 mm, resulting in a spatial resolution of 125 × 125 × 140.6 μm3; ex-
perimental duration 90 min]. For MRI scanning, mice were anesthetized
(isoflurane 1.3–1.6 vol% in oxygen at flow rate of 1.2–1.4 L/min) and 3D
T1-weighted images were acquired. Images were reconstructed in Paravision
(Bruker BioSpin) and further processed in SPM8 (www.fil.ion.ucl.ac.uk/spm), in-
cluding spatial normalization to an in-house template. On the basis of the an-
atomical brain atlas of the C57BL/6 mouse by Paxinos and Franklin (57), a
bilateral hippocampal (HPC) region was defined in normalized space on the
master template. HPC masks were back-transformed to match the individual’s
native space, and mean signal intensities were extracted. To account for possible
individual differences, HPC intensity was normalized to the intensity of the
masseter muscles (22).
Subcellular Fractionation and Western Blot Analysis. An established protocol
was used to obtain subcellular fractions (58, 59) (Fig. 4A). Briefly, hippo-
campal tissue was homogenized [10× homogenization buffer (sucrose 9%;
5 mM DTT; 2 mM EDTA; 25 mM Tris, pH 7.4); Complete Protease Inhibitor
(Roche), and Phosphatase Inhibitor Mixtures II and III (Sigma)] and centrifuged
(1,000 ×g). The postnuclear supernatant was subsequently centrifuged (12,500 ×g)
to yield crude synaptosomal and synaptosome-depleted fractions. The latter was
ultracentrifuged (176,000 × g) to yield a light membrane/Golgi fraction (P3) and
a cytoplasmic fraction (S3). The crude synaptosomal fraction was lysed in a hypo-
osmotic solution and centrifuged (25,000 × g) to obtain the synaptosomal
membrane fraction (LP1). To obtain the PSD fraction, LP1 was incubated with
1% Triton for 5–6min before ultracentrifugation (176,000 × g); the resulting
pellet contained the PSD fraction (Fig. 4I).
The various fractionated samples were electrophoresed and semidry-
transferred onto nitrocellulose membranes (Trans-Blot Turbo Blotting Sys-
tem, BioRad); membranes were blocked in 5% nonfat milk in TBS-T buffer
and then incubated with the following antibodies: Tau5 (1:2,000, Abcam
clone TAU5), p202-Tau (1:1,000, Abcam clone EPR2402), pThr231-Tau (1:1,000
Abcam 30655), pSer262-Tau (1:1,000, Santa Cruz 101813), PHF1 (1:2,000,
recognizes p396/404-Tau; kind gift from Peter Davies), GluN2B (1:1,000,
Abcam 65783), pY1472-GluN2B (1:1,000, Millipore AB5403), Fyn (1:500, Santa
Cruz sc-434), PSD-95 (1:10000, NeuroMab 75028), synaptophysin (1:1,000
NeuroMab Clone 7.2), and actin (1:2,000, abcam 8226). After incubation with
appropriate secondary antibody, antigens were revealed by ECL (Clarity, Bio-
Rad), and signal quantification was achieved using a ChemiDoc instrument
and and ImageLab software from Bio-Rad. All values were normalized and
expressed as a percentage of control values.
Electron Microscopy. Hippocampi were fixed in 4% PFA and postfixed in 4%
PFA/0.8% glutaraldehyde in 0.1 M of phosphate buffer (pH 7.4) for 1 h. The
CA1 areas were dissected from vibratome-cut axial sections of the dorsal hip-
pocampus and embedded in Epon resin. Ultrathin sections (500Å)were placed on
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nickel grids: Following antigen retrieval (boiling in citrate buffer for 30 min and a
5% BSA treatment for 30 min), sections were stained for Tau, using an immu-
nogold technique. Briefly, specimens were incubated overnight with Tau5 anti-
body (1:30, Abcam; clone TAU5), followed by appropriate gold-labeled
secondary antibody (1:15; Abcam; goat 15 nm gold). Before inspection with a
JEOL JEM-1400 transmission electron microscope, sections were counterstained
with sequential incubation with uranyl acetate and lead citrate. Images were
obtained using a Orious Sc1000 digital camera. Fifty nonoverlapping TEM
(30,000×) images of ultrathin sections per treatment group were analyzed by an
experimenter blind to the in vivo treatments.
Statistical Analysis. Data were analyzed using two-way ANOVA analysis before
application of post hoc comparisons (SPSS Inc. and GraphPad Software Inc.);
two-way repeated measures ANOVA was used to analyze the MWM data.
Differences were considered statistically significant when P < 0.05.
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